Abstract. The interstitial cells of Cajal (ICCs) are the pacemaker cells in the gastrointestinal (GI) tract. In the present study, the effects of Dangkwisoo-san (DS) on pacemaker potentials in cultured ICCs from the small intestine of the mouse were investigated. The whole-cell patch-clamp configuration was used to record pacemaker potentials from cultured ICCs and the increase in intracellular Ca 2+ concentration ([Ca 2+ i ) was analyzed in cultured ICCs using fura-2-acetoxymethyl ester. The generation of pacemaker potentials in the ICCs was observed. DS produced pacemaker depolarizations in a concentration dependent manner in current clamp mode. The 4-diphenylacetoxy-N-methyl-piperidine methiodide muscarinic M 3 receptor antagonist inhibited DS-induced pacemaker depolarizations, whereas methoctramine, a muscarinic M 2 receptor antagonist, did not. When guanosine 5'-[β-thio] diphosphate (GDP-β-S; 1 mM) was in the pipette solution, DS marginally induced pacemaker depolarizations, whereas low Na + solution externally eliminated the generation of pacemaker potentials and inhibited the DS-induced pacemaker depolarizations. Additionally, the nonselective cation channel blocker, flufenamic acid, inhibited the DS-induced pacemaker depolarizations. Pretreatment with Ca 2+ -free solution and thapsigargin, a Ca 2+ -ATPase inhibitor in the endoplasmic reticulum, also eliminated the generation of pacemaker currents and suppressed the DS-induced pacemaker depolarizations. In addition, [Ca 2+ ] i analysis revealed that DS increased [Ca 2+ ] i . These results suggested that DS modulates pacemaker potentials through muscarinic M 3 receptor activation in ICCs by G protein-dependent external and internal Ca 2+ regulation and external Na + . Therefore, DS were observed to affect intestinal motility through ICCs.
Introduction
Traditional herbal medicine is considered to be one of the most important complementary or alternative medicines in the majority of countries, and has been increasingly accepted worldwide. Despite substantial advances in modern scientific medicine, traditional medicine remains the primary form of treatment, which is readily available to the majority of individuals in several countries (1) . Traditional herbal medicines usually contain a number of compounds, which affect multiple targets (2, 3) . The combination of multiple drugs is considered to maximize therapeutic efficacy by facilitating synergistic actions and preventing potential adverse effects (2) . Dangkwisoo-san (DS) is a herbal formula, which has been traditionally used for the treatment of pain and blood stagnation caused by physical trauma in Korea (4) . DS contains constituents of nine species of herbal plants, including Angelicae gigantis Radix, Paeoniae Radix, Linderae Radix, Sappan Lignum, Cyperi Rhizoma, Carthami Flos, Persicae Semen, Cinnamomi Cortex and Glycyrrhizae Radix et Rhizoma, which have various pharmacological effects on the body (5,6). However, no investigations regarding the effects of DS on gastrointestinal (GI) motility have been previously performed, to the best of our knowledge.
The interstitial cells of Cajal (ICCs) are the pacemaker cells of the GI system and have multifunctional roles. ICCs generate rhythmic oscillations in membrane potential, termed slow waves (7) (8) (9) . The loss of ICCs is implicated in various motility disorders, which indicates that ICCs are important in the regulation of GI motility (10) . In addition, endogenous agents, including neurotransmitters, hormones and paracrine substances, modulate GI tract motility by affecting ICCs. Thus, in investigating GI motility, ICCs are the major area of interest and, at present, several novel drugs are being developed in the area of GI motility utilizing ICCs. Therefore, the present study investigated whether DS affects the pacemaker potentials of cultured ICCs and characterized the CCK receptor subtypes involved. and sacrificed by cervical dislocation. The small intestines in the region between 1 cm below the pyloric ring and the cecum were removed and opened along the mesenteric border. The luminal contents were removed by washing with Krebs-Ringer bicarbonate solution (Sigma-Aldrich). The tissues were pinned to the base of a Sylgard dish and the was mucosa removed by sharp dissection. Small tissue strips (0.2x0.2 inches) of the intestinal muscle, consisting of circular and longitudinal muscle, were equilibrated in Ca 2+ -free Hanks' solution (containing 5.36 mmol/l KCL, 125 mmol/l NaCl, 0.34 mmol/l NaOH, 0.44 mmol/l Na 2 HCO 3 , 10 mmol/l glucose, 2.9 mmol/l sucrose and 11 mmol/l HEPES; Sigma-Aldrich) for 30 min. Subsequently, the cells (density, 85%) were dispersed using an enzyme solution containing 1.3 mg/ml collagenase (Worthington Biochemical Co., Lakewood, NJ, USA), 2 mg/ml bovine serum albumin (Sigma-Aldrich), 2 mg/ml trypsin inhibitor (Sigma-Aldrich) and 0.27 mg/ml ATP (Sigma-Aldrich). The cells were plated onto sterile glass coverslips coated with murine collagen (2.5 µg/ml, BD Biosciences, Franklin Lakes, NJ, USA) in a 35-mm culture dish and then cultured at 37˚C in a 95% O 2 , 50 ml/l CO 2 incubator in a smooth muscle growth medium (Clonetics Corp., San Diego, CA, USA) supplemented with 2% antibiotics/antimycotics (Gibco Life Technologies, Grand Island, NY, USA) and murine stem cell factor (SCF; 5 ng/ml; Sigma-Aldrich). The ICCs were identified immunologically by incubation with an anti-c-kit antibody (cat. no. 12-1172; phycoerythrin-conjugated rat anti-mouse c-kit monoclonal antibody; eBioscience, San Diego, CA, USA) at a dilution of 1:50 for 20 min (11) . The ICCs were morphologically distinct from other cell types in the culture, enabling the identification of the cells using phase contrast microscopy (IX-71; Olympus Corporation, Tokyo, Japan) once they had been verified with the anti c-kit antibody.
Materials and methods

Ethics
Patch-clamp experiments.
The whole-cell patch-clamp configuration was used to record membrane potentials (current clamp) from the cultured ICCs. An axopatch ID (Axon Instruments, Inc., Foster City, CA, USA) was used to amplify membrane currents and potentials. The command pulse was applied using an IBM-compatible personal computer and pClamp software (version 6.1; Axon Instruments, Inc.). The data obtained were filtered at 5 kHz and viewed on an HM507 oscilloscope (Hameg Instruments GmbH, Melrose, MA, USA), a computer monitor and using a pen recorder (Gould 2200; Gould, Valley View, OH, USA). The results were analyzed using pClamp and Origin (version 6.0) software (MicroCal, Northampton, MA, USA). All experiments were performed at 30-32˚C.
Fura-2-acetoxymethyl ester (Fura-2-AM) loading and measurement of intracellular free calcium ion concentration [Ca
2+
] i . The cultured ICC clusters were loaded with 5 µmol/l of the acetoxymethyl ester form of fura-2 (Molecular ProbesLife Technologies, Carlsbad, CA, USA), diluted from a 1 mmol/l stock in dimethyl sulfoxide (DMSO; Sigma-Aldrich), in normal medium for 20 min at 37˚C. The recording of [Ca 2+ ] i was performed using a microfluorometric system consisting of an inverted fluorescence microscope (Diaphot 300; Nikon Corporation, Tokyo, Japan) with a dry-type fluorescence objective lens (40X; numerical aperture 0.85), a photomultiplier tube (type R 1527; Hamamatsu, Shizuoka, Japan), and a PTI-Deltascan illuminator (Photon Technology International, Inc., Edison, NJ, USA). The cells were superfused at a flow rate of 1.5 ml/min. Light was provided by a 75-W xenon lamp (UXL-75XE; Ushio, Japan). To control the excitation frequency, a chopper wheel was used to alternate the light path to monochromators (340 and 380 nm) with a frequency of 5 or 10 Hz. A short-pass dichroic mirror passed an emission light of <570 nm onto the photomultiplier tube, and the intensity was measured at 510 nm. A mechanical image mask was placed in the emission path to limit measurement to a single cell. Data acquisition and control of light application were performed using computer software (Felix version 1.1; Photon Technology International, Inc.). Due to uncertainties in calibrating the fura-2 signals in intact cells, no calibration of [Ca 2+ ] i was performed; instead, all results are reported as changes in the 340 nm/380 nm signal ratio.
Solutions and drugs.
The physiological salt solution used to bathe cells (Na + -Tyrode) contained 5 mmol/l KCl, 135 mmol/l NaCl, 2 mmol/l CaCl 2 , 10 mmol/l glucose, 1.2 mmol/l MgCl 2 and 10 mmol/l HEPES, and was adjusted to pH 7.4 with NaOH. The pipette solution contained 140 mmol/l KCl, 5 mmol/l MgCl 2 , 2.7 mmol/l K 2 ATP, 0.1 mmol/l NaGTP, 2.5 mmol/l creatine phosphate disodium, 5 mmol/l HEPES and 0.1 mmol/l EGTA, adjusted to pH 7.2 with KOH. To evaluate the effect of guanosine 5'-[β-thio] diphosphate (GDP-β-S; Sigma-Aldrich) on ICCs, GDP-β-S was included in the pipette solution. DS is composed of nine species of herbal plants, each of which were purchased from Kwangmyungdang Natural Pharmaceutical Co. (Ulsan, Korea). The constituents and formula of DS is described in Table I . A total of 60 g DS was boiled in 1 liter of distilled water in a Herb Extractor (DW-290; Daewoong Pharmaceutical Co., Ltd., Seoul, Korea) for 2 h, yielding a final 200 ml volume containing the DS extract. The supernatant was harvested in sterile conditions by centrifugation (110 x g at 4˚C for 3 min) and lyophilized through evaporation at -80˚C, yielding a final quantity of 4.6 g. The lyophilized DS extract was dissolved in 500 µl sterile phosphate-buffered saline prior to administration to the cells. The water extract of DS (voucher no. MH2014-0001) was deposited at the Division of Longevity and Biofunctional Medicine, School of Korean Medicine, Pusan National University (Pusan, Korea). All other drugs were obtained from Sigma-Aldrich. The drug treatments were dissolved in distilled water and added to bath solution to produce the desired concentrations, just prior to use. The addition of these chemicals to the bath solution did not alter the pH of the solution. 4-Diphenylacetoxy-N-methyl-piperidine methiodide [4-DAMP; 10 µM (Sigma-Aldrich)] and 5 µM thapsigargin (Sigma-Aldrich) were dissolved in DMSO for a 50 mmol/l stock solution and added to the bathing solution on the day of the experiment. The final concentration of DMSO in the bath solution remained <0.1%, and it was confirmed that this concentration of DMSO did not affect the results recorded. In addition, 25 µl methoctramine (Sigma-Aldrich) was dissolved in distilled water for a 50 mmol/l stock solution and added to the bathing solution on the day of the experiment.
Statistical analysis. All data are expressed as the mean ± standard error of the mean. Student's t-test for unpaired data was used to compare the control and experimental groups. Origin statistical software (version 6.0) was used to perform statistical analyses (MicroCal) and P<0.05 was considered to indicate a statistically significant difference.
Results
Effect of DS on pacemaker potentials in cultured ICCs.
Initially, the effects of DS on pacemaker potentials were examined. Recordings from cultured ICCs under current clamp mode (I=0) revealed spontaneous pacemaker potentials. The resting membrane potential was -51.4±2.6 mV and the amplitude was 20.2±2.3 mV. In the presence of DS (1-30 µg/ml), the membrane potentials were depolarized to 1.0±0.1 mV at 1 µg/ml, 9.7±1.3 mV at 10 µg/ml and 20.5±2.2 mV at 30 µg/ml ( Fig. 1A-D) . The summarized values and bar graph of the DS effects on pacemaker potentials are shown in Fig. 1E (n=6) . These results suggested that DS had a pacemaker depolarization effect on the ICCs.
Identification of DS receptor subtypes in cultured ICCs.
To investigate the association between DS and its receptors, muscarinic receptors were investigated as they are known to mediate the membrane depolarization and excitatory junction potential in the GI tract (12, 13) . In the GI tract, isolated ICCs express the M 2 and M 3 subtypes of the muscarinic receptors (14) . To identify the muscarinic receptor subtypes involved in the effects of DS, the ICCs were pretreated with muscarinic receptor antagonists and then treated with DS. Methoctramine, a muscarinic M 2 receptor antagonist, and 4-DAMP, a muscarinic M 3 receptor antagonist, were used for pretreatment at a concentration of 10 µM for 5 min and DS was added. Treatment with methoctramine or 4-DAMP had no effect on pacemaker potentials. Pretreatment with methoctramine did not inhibit the effect of DS (Fig. 2A) , and the membrane depolarization produced in the presence of methoctramine by DS was 19.6±2.1 mV (n=5). However, following pre-treatment with 4-DAMP, membrane depolarization by DS was found to be inhibited (Fig. 2B) , and the membrane depolarization produced in the presence of 4-DAMP by DS was 1.3±0.5 mV (n=6; Fig. 2C ). These results suggested that DS had an effect on the ICCs through the M 3 receptor.
Involvement of G proteins in DS-induced depolarizations of pacemaker potentials in cultured ICCs.
The effects of GDP-β-S, a non-hydrolysable guanosine 5'-diphosphate analogue, which permanently inactivates G-protein binding proteins (15, 16) were examined to determine whether G-proteins are involved in the effects of DS on cultured ICCs. DS (30 µg/ml) induced membrane depolarizations in ICCs (Fig. 1) . However, when GDP-β-S (1 mM) was in the pipette solution, DS (30 µg/ml) induced the membrane depolarizations only marginally (Fig. 3A) . The membrane depolarizations induced by DS were significantly affected by the presence of GDP-β-S (1 mM) in the pipette solution (n=5; Fig. 3B ). These results suggested that G-proteins are involved in the DS-induced pacemaker depolarizations in ICCs. 
A B
Effects of low external Na + concentration or nonselective cation channel blocker on DS-induced depolarizations in pacemaker potentials in cultured ICCs. To determine the characteristics of the pacemaker depolarizations induced by DS, a low external Na + concentration solution and a nonselective cation channel blocker were assessed. External Na + was substituted for by the 
same concentrations of N-methyl-D-glucamine. In the presence of an external Na + 5 mM solution, pacemaker potentials were eradicated. Under these conditions, DS (30 µg/ml) did not induce pacemaker depolarizations (Fig. 4A) . In the external Na + 5 mM solution, the pacemaker depolarizations produced by DS were 1.4±0.4 mV, which was significantly different, compared with the normal control solution (n=6; Fig. 4 ). In the presence of flufenamic acid (10 µM), a nonselective cation channel blocker, the pacemaker potentials were eradicated. Additionally, in these conditions, DS did not induce pacemaker depolarizations (Fig. 4B) . Following pretreatment with flufenamic acid, the pacemaker depolarizations produced by DS were 1.3±0.6 mV, which was significantly different, compared with the normal control solution (n=5; Fig. 4C ). These results suggested that external Na + and nonselective cation channels are involved in DS-induced depolarizations in pacemaker potentials in cultured ICCs. , DS was applied under external Ca 2+ -free conditions and in the presence of thapsigargin, a Ca 2+ -ATPase inhibitor of endoplasmic reticulum. In external Ca 2+ -free solution, pacemaker potentials were completely eradicated. In this condition, DS had no effect on pacemaker potentials (Fig. 5A) . These effects were significantly different, compared with those of DS in the normal Ca 2+ solution (n=6; Fig. 5 ). In addition, pretreatment with thapsigargin (5 µM) suppressed the pacemaker potentials and, in this condition, DS had no effect on pacemaker potentials (Fig. 5B) . In the presence of thapsigargin, the effects were significantly different, compared with DS in the absence of thapsigargin (n=6; Fig. 5C ] i oscillations were observed in ICC clusters treated with 5 µM fura-2-AM. Fig. 6 shows the changes in the 340 nm/380 nm signal ratio. In normal conditions, spontaneous [Ca 2+ ] i oscillations were induced (Fig. 6A) . In the presence of DS (30 µg/ml), the [Ca 2+ ] i in ICCs was increased (Fig. 6B) . These results suggested that DS increased the [Ca 2+ ] i in ICCs.
Effects of external
Discussion
In the present study, ICCs were used to investigate the association between DS and GI motility. DS has not been previously used to treat GI motility diseases, and this is the first study, to the best of our knowledge, regarding the potential effects of DS on ICCs. Due to the central role of ICCs in GI motility, loss of these cells is detrimental in disorders, including inflammatory bowel disease, chronic idiopathic intestinal pseudo-obstruction, intestinal obstruction with hypertrophy, achalasia, Hirschsprung disease, juvenile pyloric stenosis, juvenile intestinal obstruction and anorectal malformation (10) . Therefore, investigation into the biology of ICCs provides novel opportunities to develop drugs with the ability to regulate GI motility.
Acetylcholine depolarizes the membrane potential of slow waves and leads to contraction of gastrointestinal smooth muscle (18) . Therefore, muscarinic receptors are important in the regulation of GI motility. Muscarinic receptors are composed of five subtypes, M 1 -M 5 . However, GI smooth muscles express the M 2 and M 3 subtypes of the muscarinic receptors. M 2 receptors are more widely distributed than M 3 receptors, in the ratio of 80% M 2 to 20% M 3 (19) . In molecular studies, mRNA of M 2 and M 3 receptors were detected using reverse-transcription polymerase chain reaction from isolated ICCs (14) . In the present study, 4-DAMP, a muscarinic M 3 receptor antagonist, inhibited DS-induced pacemaker depolarizations, whereas methoctramine, a muscarinic M 2 receptor antagonist, did not. Thus, it appears that DS modulated pacemaker potentials through muscarinic M 3 receptor-mediated pathways in the ICCs of the mouse small intestine (Fig. 2) .
Generally, DS has been traditionally used in Korea for the treatment of pain and blood stagnation caused by physical trauma (4) . In the present study, however, it was found that DS modulated GI motility using ICCs. DS produced pacemaker depolarizations in current clamp mode (Fig. 1) . 4-DAMP, a muscarinic M 3 receptor antagonist, inhibited DS-induced pacemaker depolarizations, whereas methoctramine, a muscarinic M 2 receptor antagonist, did not (Fig. 2) . When GDP-β-S (1 mM) was included in the pipette solution, DS induced pacemaker depolarizations marginally (Fig. 3) . Low Na + solution externally inhibited the DS-induced pacemaker depolarizations. Additionally, the nonselective cation channel blocker, flufenamic acid, inhibited the DS-induced pacemaker depolarizations (Fig. 4) . Pretreatment with Ca 2+ -free solution and thapsigargin, a Ca 2+ -ATPase inhibitor in the endoplasmic reticulum, suppressed the DS-induced pacemaker depolarizations (Fig. 5) . In addition, [Ca 2+ ] i analysis revealed that DS increased [Ca 2+ ] i (Fig. 6) . These results suggested that DS may affect GI motility via the modulation of pacemaker potentials through muscarinic M 3 receptor activation by a G protein-dependent external and internal Ca 2+ regulation and external Na + in ICCs. In conclusion, the present data suggested that DS may have an ability to modulate the pacemaker potentials in ICCs. In future investigations, the active compounds within DS and their mechanism of action require detailed investigation.
